Cargando…
Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications
The COVID-19 pandemic has introduced a global public health threat unparalleled in our history. The most severe cases are marked by ARDS attributed to microvascular thrombosis. Hypercoagulability, resulting in a profoundly prothrombotic state, is a distinct feature of COVID-19 and is accentuated by...
Autores principales: | Meizoso, Jonathan P., Moore, Hunter B., Moore, Ernest E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Surgeons. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982779/ https://www.ncbi.nlm.nih.gov/pubmed/33766727 http://dx.doi.org/10.1016/j.jamcollsurg.2021.02.019 |
Ejemplares similares
-
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection
por: Wright, Franklin L., et al.
Publicado: (2020) -
Do not drink and lyse: alcohol intoxication increases fibrinolysis shutdown in injured patients
por: Stettler, Gregory R., et al.
Publicado: (2020) -
Fibrinolysis Shutdown and Thrombosis in Severe COVID-19
por: Seheult, Jansen N., et al.
Publicado: (2020) -
Hyperfibrinolysis and fibrinolysis shutdown in patients with traumatic brain injury
por: Nakae, Ryuta, et al.
Publicado: (2022) -
Harmful or Physiologic: Diagnosing Fibrinolysis Shutdown in a Trauma Cohort With Rotational Thromboelastometry
por: Gomez-Builes, J. Carolina, et al.
Publicado: (2018)